炎症预测心肌炎患者室速消融后复发
该研究纳入125例心肌炎合并药物难治性室速接受消融的患者,术前分期识别活动期与既往心肌炎,主要终点为12个月室速复发。活动期是12个月复发的唯一预测因子(HR 9.5),活动期和宽边界区与全程复发相关;既往期再次消融后无室速发作。
要点
- 活动期心肌炎是12个月室速复发的独立预测因子(HR 9.5)。
- 活动期和宽边界区均与随访期间任意时间复发相关。
- 避免在活动期行室速消融,急性期后复发消融常获益。
核心结论
- 活动期心肌炎应避免室速消融,急性期后复发室速消融常有益。
研究设计与样本
- 连续纳入125例心肌炎合并药物难治性室速行消融患者,术前评估活动期与既往期,回顾性识别复发预测因子。
主要发现
- 12个月时25例(20%)复发,末次随访(中位63个月)43例(34%)复发。
- 多变量分析显示活动期是12个月复发的唯一预测因子(HR 9.5,95%CI 2.6-35.3,P<0.001)。
- 活动期和宽边界区均与随访期间任意时间复发相关。
- 23例在既往期再次消融后未再出现室速发作。
关键数值与推荐
- 活动期47例(38%),既往期78例(62%);宽边界区25例(20%)。
- 12个月复发25例(20%),末次随访复发43例(34%)。
临床怎么用
- 术前应评估心肌炎分期,活动期患者避免室速消融。
- 急性期后复发室速可考虑消融,再次消融在既往期可能有效。
局限性
- 回顾性识别预测因子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the risk stratification of patients with myocarditis undergoing ventricular tachycardia (VT) ablation. OBJECTIVES: This study sought to describe VT ablation results and identify factors associated with arrhythmia recurrences in a cohort of patients with myocarditis. METHODS: The authors enrolled 125 consecutive patients with myocarditis, undergoing VT ablation. Before ablation, disease stage was evaluated, to identify active (AM) versus previous myocarditis (PM). The primary study endpoint was assessment of VT recurrences by 12-month follow-up. Predictors of VT recurrences were retrospectively identified. RESULTS: All patients (age 51 ± 14 years, 91% men, left ventricular ejection fraction 52% ± 9%) had history of myocarditis diagnosed by endomyocardial biopsy (59%) and/or cardiac magnetic resonance (90%). Furthermore, all had multiple episodes of drug-refractory VTs. Multimodal pre-procedural staging identified 47 patients with AM (38%) and 78 patients with PM (62%). All patients showed low-voltage areas (LVA) at electroanatomical map (97% epicardial or endoepicardial); of them, 25 (20%) had wide borderzone (WBZ, constituting >50% of the whole LVA). VT recurrences were documented in 25 patients (20%) by 12 months, and in 43 (34%) by last follow-up (median 63 months; interquartile range: 39 to 87). At multivariable analysis, AM stage was the only predictor of VT recurrences by 12 months (hazard ratio: 9.5; 95% confidence interval: 2.6 to 35.3; p < 0.001), whereas both AM stage and WBZ were associated with arrhythmia recurrences anytime during follow-up. No VT episodes were found after redo ablation was performed in 23 patients during PM stage. CONCLUSION: Our findings suggest that VT ablation should be avoided during AM, but is often of benefit for recurrent VT after the acute phase of myocarditis.
引用
- Peretto G, Sala S, Basso C, et al. Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis. J Am Coll Cardiol. 2020. PMID: 33004129. doi:10.1016/j.jacc.2020.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。